---
title: "Trend — insulinspritzen - Flapen"
canonical_url: "https://flapen.com/research/de/gewerbe-industrie-wissenschaft/insulinspritzen/trend"
last_updated: "2026-07-21T07:26:57.042Z"
locale: en
meta:
  description: "insulinspritzen shows low returns (0.3%), but a failed launch gate (market size, growth, or returns) keeps it on the watch list. Data updated Jul 2026."
  "og:description": "insulinspritzen shows low returns (0.3%), but a failed launch gate (market size, growth, or returns) keeps it on the watch list. Data updated Jul 2026."
  "og:title": "Trend — insulinspritzen - Flapen"
---

# **insulinspritzen**

**Worth a look**

Shows low returns (0.3%), but a failed launch gate (market size, growth, or returns) keeps it on the watch list.

Market size 58Growth 57Conversion 73Competition 80Returns 98Price range 64Avg price 74Brand share 76Review moat 93Quality gap 65

**Returns**

**Incredible****0.3%**

return rate — above 6% kills the launch gate

**Review moat**

**Great****145.31**

avg incumbent reviews — the moat a new listing must climb

**Competition**

**Great****35%**

top-5 click share — an open shelf

**Brand share**

**Great****59%**

top-5 brand share — no brand owns this niche

**Avg price**

**Good****€14.87**

avg listing price — sweet spot $15–$100

**Conversion**

**Good****6.8%**

search→purchase rate — share of searches ending in a sale

**Quality gap**

**Good****4.4★**

avg incumbent rating — lower means beatable quality

**Price range**

**Good****€6.25–€30.57**

cheapest to priciest tracked listing — scored on the share inside $15–$100

**Market size**

**Good****€467K**

€467K/yr · 461K searches

**Growth**

**Good****+31.2%**

90-day search growth — must beat 0% to launch